GlobalData on MSN10mon
Nyxoah’s nerve stimulation device meets endpoints in sleep apnoea studyNyxoah’s hypoglossal nerve stimulation system, Genio, met the co-primary endpoints at 12 months in the pivotal DREAM trial in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback